Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 3Osteoporosis, Postmenopausal 1Leiomyoma 1Endometriosis 1

Interventions

ulipristal acetate 20Uterine Myomectomy 19telapristone acetate 18vilaprisan 12relugolix 12Leuprolide 11Uterine Artery Embolization 10estradiol, norethindrone drug combination 9asoprisnil 9Estradiol 8elagolix 7Tranexamic Acid 7Mifepristone 7Bupivacaine 7ulipristal 6Norethindrone Acetate 6Hysterectomy 6Saline Solution 5linzagolix 4epigallocatechin gallate 4Sodium Chloride 4Misoprostol 4Letrozole 4Vitamin B 6 3Tablets 3Surveys and Questionnaires 3Sugars 3Radiofrequency Ablation 3Lidocaine 3Hysteroscopy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leiomyoma × tibolone × Clear all
NCT05568940 2024-05-30

eTAPE

McGill University Health Centre/Research Institute of the McGill University Health Centre

Withdrawn

Endometriosis, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡